QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML

Clinical trial NCT03050216 · COMPLETED

Trial details

NCT number: NCT03050216
Sponsor: Masonic Cancer Center, University of Minnesota
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2017-05-16
Primary completion: 2019-12-15
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.